Detailed and insightful market overview for the Biopsy Market focusing on the market size, growth trends, significant drivers and challenges, emerging opportunities, and key players
Anticipated Growth in Revenue:
The Biopsy Market size is expected to grow from US$ 32.38 Bn in 2023 to US$ 67.83 Bn by 2030. The Global Biopsy Market is expected to grow at a CAGR of 11.14% through the forecast period (2024 to 2030).
Biopsy Market Overview: Key Trends and Insights
Regional Insights and Growth Opportunities in the Biopsy Market
The Regional Analysis section offers a comprehensive overview of the current landscape of the Biopsy market across each participating country. Given the intricate dynamics of the Biopsy industry, local perspectives are essential. The market is divided into six key regions: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In-depth analysis of each region covers market size, growth rate, import and export data, and other relevant specifics.
Biopsy Market Segmentation: The Art of Unveilingby Module
by Product
Instruments
Kits and Consumables
Services
by Type
Tissue Biopsies
Liquid Biopsies
Others
by Application
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Liver Cancers
Pancreatic Cancers
Ovarian Cancers
Others
Who Leads the Biopsy Market? Meet the Global Manufacturers Shaping the Future of the Industry
North America
1. Illumina, Inc.(U.S)
2. Quest Diagnostics (U.S)
3. Abbott Laboratories (U.S)
4. GenMark Diagnostics(U.S)
5. Bio-Rad Laboratories (U.S)
6. Agilent Technologies (U.S)
7. Biomarker Technologies (U.S)
8. Coherent, Inc. (U.S)
9. Cardinal Health (U.S)
10. BD (Becton, Dickinson and Company) (U.S)
11. Myriad Genetics (U.S)
12. Hologic, Inc. (U.S)
13. Biocept, Inc. (U.S)
14. Thermo Fisher Scientific, Inc. (U.S)
15. Danaher (U.S)
16. Guardant Health (U.S)
17. Exact Sciences Corporation (U.S)
18. Freenome Holdings, Inc. (U.S)
19. Biodesix (Integrated Diagnostics) (U.S)
20. HelioHealth (Laboratory for Advanced Medicine) (U.S)
21. Genesystems, Inc. (Genesys Biolabs)(U.S)
22. GRAIL, Inc. (U.S)
Europe
1. ANGLE Plc (U.K)
2. Oncimmune (U.K)
3. Epigenomics AG (Germany)
4. Qiagen N.V. (Netherlands)
5. F. Hoffmann-La Roche Ltd. (Switzerland)
Asia Pacific
1. Sysmex Corporation (Japan)
2. Olympus(Japan)
3. Lucence Diagnostics Pte. Ltd. (Singapore)
Key Insights Unveiled in the Biopsy Market Report:
Answer: Find out how leading companies are enhancing their market share, through product innovations, partnerships, and strategic collaborations.
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.